Daily intraparaventricular orexin-a treatment induces weight loss in rats

Colleen M. Novak, James A. Levine

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The neuropeptide orexin (hypocretin) increases energy expenditure partially through increasing spontaneous physical activity. The ability of exogenous orexin to alter body weight has never been established, however. We sought to determine whether orexin-A microinjected into the paraventricular nucleus of the hypothalamus (PVN) induced weight loss in rats. Chronic guide cannulae were implanted into rats, aimed at the PVN. Rats were given daily microinjections of orexin (0.5 nmol) or vehicle into the PVN for 6 days; food intake and body weight were measured daily. In a separate group of rats, we injected orexin-A and vehicle intra-PVN and measured daily activity levels. Daily orexin treatment induced weight loss: orexin-A-treated rats lost significantly more weight than their vehicle-injected counterparts without a significant difference in food intake. Rats were significantly more active after intra-PVN orexin compared to vehicle. These results support the concept that orexinergic agents have the potential to produce negative energy balance through increasing physical activity. This presents a promising, untapped potential resource for weight loss.

Original languageEnglish (US)
Pages (from-to)1493-1498
Number of pages6
JournalObesity
Volume17
Issue number8
DOIs
StatePublished - Aug 2009
Externally publishedYes

Fingerprint

Paraventricular Hypothalamic Nucleus
Weight Loss
Hypothalamus
Therapeutics
Eating
Body Weight
Microinjections
Neuropeptides
Energy Metabolism
Weights and Measures
Orexins

ASJC Scopus subject areas

  • Endocrinology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Daily intraparaventricular orexin-a treatment induces weight loss in rats. / Novak, Colleen M.; Levine, James A.

In: Obesity, Vol. 17, No. 8, 08.2009, p. 1493-1498.

Research output: Contribution to journalArticle

Novak, Colleen M. ; Levine, James A. / Daily intraparaventricular orexin-a treatment induces weight loss in rats. In: Obesity. 2009 ; Vol. 17, No. 8. pp. 1493-1498.
@article{b7f59f6c3ea44085b38e0c22475f72b8,
title = "Daily intraparaventricular orexin-a treatment induces weight loss in rats",
abstract = "The neuropeptide orexin (hypocretin) increases energy expenditure partially through increasing spontaneous physical activity. The ability of exogenous orexin to alter body weight has never been established, however. We sought to determine whether orexin-A microinjected into the paraventricular nucleus of the hypothalamus (PVN) induced weight loss in rats. Chronic guide cannulae were implanted into rats, aimed at the PVN. Rats were given daily microinjections of orexin (0.5 nmol) or vehicle into the PVN for 6 days; food intake and body weight were measured daily. In a separate group of rats, we injected orexin-A and vehicle intra-PVN and measured daily activity levels. Daily orexin treatment induced weight loss: orexin-A-treated rats lost significantly more weight than their vehicle-injected counterparts without a significant difference in food intake. Rats were significantly more active after intra-PVN orexin compared to vehicle. These results support the concept that orexinergic agents have the potential to produce negative energy balance through increasing physical activity. This presents a promising, untapped potential resource for weight loss.",
author = "Novak, {Colleen M.} and Levine, {James A.}",
year = "2009",
month = "8",
doi = "10.1038/oby.2009.91",
language = "English (US)",
volume = "17",
pages = "1493--1498",
journal = "Obesity",
issn = "1930-7381",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Daily intraparaventricular orexin-a treatment induces weight loss in rats

AU - Novak, Colleen M.

AU - Levine, James A.

PY - 2009/8

Y1 - 2009/8

N2 - The neuropeptide orexin (hypocretin) increases energy expenditure partially through increasing spontaneous physical activity. The ability of exogenous orexin to alter body weight has never been established, however. We sought to determine whether orexin-A microinjected into the paraventricular nucleus of the hypothalamus (PVN) induced weight loss in rats. Chronic guide cannulae were implanted into rats, aimed at the PVN. Rats were given daily microinjections of orexin (0.5 nmol) or vehicle into the PVN for 6 days; food intake and body weight were measured daily. In a separate group of rats, we injected orexin-A and vehicle intra-PVN and measured daily activity levels. Daily orexin treatment induced weight loss: orexin-A-treated rats lost significantly more weight than their vehicle-injected counterparts without a significant difference in food intake. Rats were significantly more active after intra-PVN orexin compared to vehicle. These results support the concept that orexinergic agents have the potential to produce negative energy balance through increasing physical activity. This presents a promising, untapped potential resource for weight loss.

AB - The neuropeptide orexin (hypocretin) increases energy expenditure partially through increasing spontaneous physical activity. The ability of exogenous orexin to alter body weight has never been established, however. We sought to determine whether orexin-A microinjected into the paraventricular nucleus of the hypothalamus (PVN) induced weight loss in rats. Chronic guide cannulae were implanted into rats, aimed at the PVN. Rats were given daily microinjections of orexin (0.5 nmol) or vehicle into the PVN for 6 days; food intake and body weight were measured daily. In a separate group of rats, we injected orexin-A and vehicle intra-PVN and measured daily activity levels. Daily orexin treatment induced weight loss: orexin-A-treated rats lost significantly more weight than their vehicle-injected counterparts without a significant difference in food intake. Rats were significantly more active after intra-PVN orexin compared to vehicle. These results support the concept that orexinergic agents have the potential to produce negative energy balance through increasing physical activity. This presents a promising, untapped potential resource for weight loss.

UR - http://www.scopus.com/inward/record.url?scp=67749084128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67749084128&partnerID=8YFLogxK

U2 - 10.1038/oby.2009.91

DO - 10.1038/oby.2009.91

M3 - Article

C2 - 19343016

AN - SCOPUS:67749084128

VL - 17

SP - 1493

EP - 1498

JO - Obesity

JF - Obesity

SN - 1930-7381

IS - 8

ER -